Liquidia Corp (LQDA)

$46.63 +2.42 (5.47%)
Market Cap 3.69B
Revenue (ttm) 14.00M
Net Income (ttm) -130.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 66.50
Profit Margin -931.36%
Debt to Equity Ratio 8.73
Volume 1,936,800
Avg Vol 1,730,196
Day's Range N/A - N/A
Shares Out 87.00M
Stochastic %K 100%
Beta 0.48
Analysts Strong Sell
Price Target $43.00

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneou...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 328 4400
Fax: 919 328 4402
Address:
419 Davis Drive, Suite 100, Morrisville, United States
KeelinTime
KeelinTime Feb. 4 at 1:43 AM
$LQDA
0 · Reply
Gambaa
Gambaa Feb. 3 at 11:00 PM
$LQDA 💪
0 · Reply
JFais
JFais Feb. 3 at 9:27 PM
$LQDA (L) Hit a double for us today (+103% gain) Glad it's worked out great in such a short time, but be aware of the upcoming binary catalyst (judge decision for IP) and position yourselves accordingly (sleep well at night) Whether that means partial profits/size down, etc Or no action if you feel good about current exposure As with every position, we try to plan for ALL possible scenarios (eyes wide open to risks)
0 · Reply
MrMulally
MrMulally Feb. 3 at 9:03 PM
$MNKD $LQDA much better close for once!!! We can get used to this🤪
0 · Reply
Prezzy
Prezzy Feb. 3 at 8:47 PM
$LQDA Love seeing the haters mad in the comments. Don't worry we still have room to 100 so jump in now!
0 · Reply
msgu1021
msgu1021 Feb. 3 at 8:39 PM
$LQDA holly macro! I am glad I have a little position in this monster.. looks pretty strong on day like this.
0 · Reply
History101
History101 Feb. 3 at 8:39 PM
$IBRX I love when my portfolio is green on a DEEP RED market day. GLTALs!! $SLS $LQDA $GLSI
1 · Reply
trondisc
trondisc Feb. 3 at 8:20 PM
If you’re a $MNKD pre-bullsh*t-unnecessary-reverse-split holder & aren’t livid with trade secret theft $LQDA skyrocketing onward to 50, you are also complacent like #ComatoseCastagnant. #BuyOut #HostileTakeover #FireHim #MathIsNotHard #PaltryProfit #SingleDigitPurgatory #CatastrophicExecutiveOfficer #ChiefExcuseOfficer #CorruptExecutiveOfficer #InTechnosphereWeTrust #MikeHas2Go #TrueLongs #PreReverseSplit #GiveHimTheGuillotine #DecemberMassacre #EarnedTheRight2PissAndMoan #RestAndNeverGrow #MikeHas2Go #MiseryMike #RetirementUnfux0red #ReadySetInhale #Access4Patients #MediocreMike #NewLeadershipNow #BotchedUAE #MoronMike #MidTierMike #MalignantMike #MalaiseMike #MisguidedMike #MinorLeagueMike #MismanagementMike #PfefferSucks
1 · Reply
stevemano
stevemano Feb. 3 at 6:29 PM
$LQDA $MNKD I have been long and I have been short on liquid D technology. It is certainly on a tear. But I have pointed out negative priced earnings ratio, negative return on investment just a bunch of negatives all over the place. I am looking very closely as to when to enter a new short position and dump my long shares. Have a great day.
1 · Reply
MrMulally
MrMulally Feb. 3 at 5:03 PM
$MNKD $LQDA this post might get me blocked here for LQDA haters but you can’t blame me as an investor. You go where the $$$$ is. I have been dating MNKD for over 10 yrs (75% gain)but only cheated with LQDA last May and she puts out🤣🤣 (187% gain in just 8 months)
5 · Reply
Latest News on LQDA
Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 10:25 PM EST - 20 days ago

Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored

Jan 8, 2026, 2:00 PM EST - 26 days ago

Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored

Liquidia Corporation (LQDA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 19, 2025, 2:38 AM EST - 2 months ago

Liquidia Corporation (LQDA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Liquidia Corporation: Heading In The Right Direction

Nov 5, 2025, 6:16 PM EST - 3 months ago

Liquidia Corporation: Heading In The Right Direction

Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 12:16 PM EST - 3 months ago

Liquidia Corporation (LQDA) Q3 2025 Earnings Call Transcript

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Nov 3, 2025, 8:00 AM EST - 3 months ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Liquidia Corporation (LQDA) Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies Transcript

Oct 29, 2025, 2:46 PM EDT - 3 months ago

Liquidia Corporation (LQDA) Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies Transcript

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 27, 2025, 8:30 AM EDT - 3 months ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Oct 7, 2025, 6:30 AM EDT - 4 months ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 27, 2025, 8:30 AM EDT - 5 months ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Aug 13, 2025, 2:51 PM EDT - 6 months ago

Liquidia Analysts Raise Their Forecasts Following Q2 Results

Why Is Liquidia Stock Trading Higher On Tuesday?

Aug 12, 2025, 2:25 PM EDT - 6 months ago

Why Is Liquidia Stock Trading Higher On Tuesday?

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 12:43 PM EDT - 6 months ago

Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 12, 2025, 6:30 AM EDT - 6 months ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

What Next For Liquidia After Launch?

Jun 30, 2025, 10:40 AM EDT - 7 months ago

What Next For Liquidia After Launch?

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 23, 2025, 4:34 PM EDT - 8 months ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

Jun 2, 2025, 6:30 AM EDT - 8 months ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 11:08 AM EDT - 8 months ago

These Analysts Boost Their Forecasts On Liquidia

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 8 months ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 23, 2025, 2:28 PM EDT - 9 months ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 12, 2025, 6:00 AM EDT - 9 months ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

May 10, 2025, 9:29 PM EDT - 9 months ago

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 8, 2025, 6:30 AM EDT - 9 months ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

May 5, 2025, 4:06 PM EDT - 9 months ago

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 2, 2025, 5:28 PM EDT - 9 months ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

May 1, 2025, 8:00 AM EDT - 9 months ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Arquitos Capital's Largest Holdings  For Q1 2025

Apr 30, 2025, 9:30 AM EDT - 9 months ago

Arquitos Capital's Largest Holdings  For Q1 2025

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 11 months ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 11 months ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 28, 2025, 9:30 AM EDT - 11 months ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:56 AM EDT - 11 months ago

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 19, 2025, 6:30 AM EDT - 11 months ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Mar 12, 2025, 8:00 AM EDT - 11 months ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Nov 15, 2024, 10:20 AM EST - 1 year ago

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:40 PM EST - 1 year ago

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Sep 30, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Sep 29, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

Sep 24, 2024, 11:00 AM EDT - 1 year ago

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Sep 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

Sep 21, 2024, 11:00 AM EDT - 1 year ago

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Sep 20, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

KeelinTime
KeelinTime Feb. 4 at 1:43 AM
$LQDA
0 · Reply
Gambaa
Gambaa Feb. 3 at 11:00 PM
$LQDA 💪
0 · Reply
JFais
JFais Feb. 3 at 9:27 PM
$LQDA (L) Hit a double for us today (+103% gain) Glad it's worked out great in such a short time, but be aware of the upcoming binary catalyst (judge decision for IP) and position yourselves accordingly (sleep well at night) Whether that means partial profits/size down, etc Or no action if you feel good about current exposure As with every position, we try to plan for ALL possible scenarios (eyes wide open to risks)
0 · Reply
MrMulally
MrMulally Feb. 3 at 9:03 PM
$MNKD $LQDA much better close for once!!! We can get used to this🤪
0 · Reply
Prezzy
Prezzy Feb. 3 at 8:47 PM
$LQDA Love seeing the haters mad in the comments. Don't worry we still have room to 100 so jump in now!
0 · Reply
msgu1021
msgu1021 Feb. 3 at 8:39 PM
$LQDA holly macro! I am glad I have a little position in this monster.. looks pretty strong on day like this.
0 · Reply
History101
History101 Feb. 3 at 8:39 PM
$IBRX I love when my portfolio is green on a DEEP RED market day. GLTALs!! $SLS $LQDA $GLSI
1 · Reply
trondisc
trondisc Feb. 3 at 8:20 PM
If you’re a $MNKD pre-bullsh*t-unnecessary-reverse-split holder & aren’t livid with trade secret theft $LQDA skyrocketing onward to 50, you are also complacent like #ComatoseCastagnant. #BuyOut #HostileTakeover #FireHim #MathIsNotHard #PaltryProfit #SingleDigitPurgatory #CatastrophicExecutiveOfficer #ChiefExcuseOfficer #CorruptExecutiveOfficer #InTechnosphereWeTrust #MikeHas2Go #TrueLongs #PreReverseSplit #GiveHimTheGuillotine #DecemberMassacre #EarnedTheRight2PissAndMoan #RestAndNeverGrow #MikeHas2Go #MiseryMike #RetirementUnfux0red #ReadySetInhale #Access4Patients #MediocreMike #NewLeadershipNow #BotchedUAE #MoronMike #MidTierMike #MalignantMike #MalaiseMike #MisguidedMike #MinorLeagueMike #MismanagementMike #PfefferSucks
1 · Reply
stevemano
stevemano Feb. 3 at 6:29 PM
$LQDA $MNKD I have been long and I have been short on liquid D technology. It is certainly on a tear. But I have pointed out negative priced earnings ratio, negative return on investment just a bunch of negatives all over the place. I am looking very closely as to when to enter a new short position and dump my long shares. Have a great day.
1 · Reply
MrMulally
MrMulally Feb. 3 at 5:03 PM
$MNKD $LQDA this post might get me blocked here for LQDA haters but you can’t blame me as an investor. You go where the $$$$ is. I have been dating MNKD for over 10 yrs (75% gain)but only cheated with LQDA last May and she puts out🤣🤣 (187% gain in just 8 months)
5 · Reply
ChartBandit02
ChartBandit02 Feb. 3 at 2:54 PM
$LQDA
0 · Reply
MarketPro
MarketPro Feb. 2 at 7:55 PM
$LQDA Chart Update
1 · Reply
local42r
local42r Feb. 2 at 7:49 PM
$LQDA here comes that Ole 50 $ I've been talking about.
0 · Reply
BDE_Worldwide
BDE_Worldwide Feb. 2 at 7:47 PM
$LQDA
0 · Reply
KeelinTime
KeelinTime Feb. 2 at 7:00 PM
$LQDA
0 · Reply
stevemano
stevemano Feb. 2 at 6:34 PM
$LQDA negative earnings negative fundamentals. Lots of pumpers!
2 · Reply
CrispDry
CrispDry Feb. 2 at 5:17 PM
$LQDA what’s the price target if judge gives the OK? Basically it’s destroying $UTHR on sales and growth
2 · Reply
KeelinTime
KeelinTime Feb. 1 at 2:42 PM
$LQDA
0 · Reply
ChartBandit02
ChartBandit02 Jan. 30 at 7:41 PM
$LQDA how are the trails going
0 · Reply
kiwitc2000
kiwitc2000 Jan. 30 at 6:34 PM
$LQDA Holding its own compared to market no matter what anybody says. Same with $CSX.
0 · Reply
Rolf1968
Rolf1968 Jan. 29 at 7:56 PM
$LQDA 3 dollar stock
1 · Reply
chiguy95
chiguy95 Jan. 29 at 4:06 PM
$LQDA -Company announces they're releasing updated trial data/earnings - The data/earnings are good - Share price gets walked down so whales can enter for cheaper - Once they're in, they let it run 5-7% over the next several days - Share price then tunnels for a few weeks - Out of nowhere, intraday price swings start fluctuating like a penny stock - Repeat starting at bullet point #1
1 · Reply